| Literature DB >> 34943313 |
Catherine Malysse1, Rita Pilar Romero-Galisteo1,2, Jose Antonio Merchán-Baeza3, J Ignacio Durán-Millán1,2, Manuel González-Sánchez1,2, Alejandro Galan-Mercant4,5.
Abstract
Cancer is one of the main causes of death in children, however, the techniques and interventions applied allow the cure of 80% of diagnosed cases. The aim of this review was to determine the benefits of a health and physical activity promotion programme to reduce pain and fatigue symptoms in children and adolescents with cancer. The databases PubMed, Embase, Scopus, Cochrane, Web of Science and PEDro were searched between December 2020 and January 2021 to elaborate this review, using the keywords child, cancer, exercise, fatigue and pain. The review was preregistered in PROSPERO (ID CRD42021262183). Six studies, out of 937 identified at baseline, were finally included in the review: four randomised controlled trials and two quasi-experimental studies. The total sample size of all the included studies was of 474 participants with very different types of cancer and evolution, and outcome variables were pain, fatigue, physical activity level, self-efficacy and quality of life. A health and physical activity promotion programme seems to improve fatigue in paediatric cancer patients and survivors, but no significant results were found related to pain.Entities:
Keywords: cancer; child; coaching; fatigue; health promotion; pain; physical activity
Year: 2021 PMID: 34943313 PMCID: PMC8700190 DOI: 10.3390/children8121119
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1PRISMA flow diagram.
Characteristics and methodological quality of the studies analysed according to the PEDro scale.
| Author and Year | Sample Size | Study Design | Cancer Type | Age | Intervention | PEDro Scale |
|---|---|---|---|---|---|---|
| Cox et al. [ | n = 77: | Randomized controlled trial (RCT) | Acute lymphoblastic leukaemia | 4–18 years | E.G.: | 6/10 |
| Hooke et al. [ | n = 30 | Quasi-experimental study with a nonrandomized comparative group design | - Acute lymphoblastic leukaemia | 6–18 years | “Kids Are Moving” programme starting the second month of cancer treatment. This programme is based on typical PA for children, such as playing hide and seek or riding a bike, and was implemented in combination with PA coaching in five steps: determining the patients’ current PA level, assessing possible health barriers to PA, determining the stage of change the patients and their caretakers are in, writing the personalised PA prescription with recommendations on frequency and intensity, and providing information on resources. | N/A |
| Lam et al. [ | n = 70 | Randomized controlled trial (RCT) | Not specified | 9–18 years | E.G.: | 7/10 |
| Li et al. [ | n = 222 | Randomized controlled trial (RCT) | Child cancer survivors (type not specified) | 9–16 years | E.G.: | 7/10 |
| Mendoza et al. [ | n = 60 | Pilot randomized controlled trial (RCT) | Child cancer survivors (type not specified) | 14–18 years | E.G.: | 5/10 |
| Ovans et al. [ | n = 15 | Quasi-experimental study | Brain tumours | 7–18 years | A 12-week intervention combining: | N/A |
Abbreviations: C.G.: control group; E.G.: experimental group; N/A: not applicable; n: sample size; P.A.: physical activity; ROM: range of movement.
Outcome measures of the analysed studies.
| Author and Year | Time of Assessment | Outcome Variables | Assessment Tools | Outcomes: Mean (SD) | Conclusions | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Groups | T0 | T1 | T2 | T3 | ||||||
| Cox et al. [ | T0: initial assessment (n = 107). T1: 8 weeks (n = 97). T2: 15 weeks | Health-related quality of life (includes pain): patients and parents. | Patients: Child Health Questionnaire a (bodily pain) | E.G. | 59.58 (28.36) | 55.58 (25.19) | 60.73 (25.53) | 71.58 (23.31) | Although there were improvements in outcomes over time, there were no statistically significant differences between the two groups | |
| C.G. | 56.38 (26.82) | 65.23 (26.37) | 66.67 (25.05) | 76.34 (22.78) | ||||||
| Parents: Child Health Questionnaire (bodily pain) | E.G. | 46.79 (24.24) | 46.6 (19.14) | 58.37 (19.02) | 71.08 (23.78) | |||||
| C.G. | 49.81 (23) | 50.42 (16.01) | 60.21 (22.55) | 72.38 (25.26) | ||||||
| PA patterns (hours/day) | SenseWear Pro III accelerometer | E.G. | - | 8.45 (9.94) | 5.81 (5.91) | 11.86 (10.06) | ||||
| C.G. | - | 9.32 (12.26) | 7.84 (10.17) | 12.84 (12.80) | ||||||
| Hooke et al. [ | T1: 2 months (n = 28). T2: 4 months b (n = 21). T3: 6 months (n = 12). | PA level | Self-report: leisure score index of the GLTEQ | E.G. | 54.9 (10.8) | 60.4 (7.8) | 51.1 (10.2) | No statistically significant differences have been found in the outcomes between both groups of over time. | ||
| Historical C.G b. | - | 49.3 (63.1) | - | |||||||
| Actigraphy c: Actigraph GT3X accelerometer. | E.G. | Steps/day | 4000 | 3500 | 4300 | |||||
| PA minutes/day | 95 | 70 | 70 | |||||||
| % sedentarism/day | 80 | 85 | 85 | |||||||
| Fatigued | FS-Cb and FS-A b | E.G. | Combined group | 53.9 (2.0) | 51.0 (2.0) | 48.7 (2.6) | ||||
| ALL | 59.6 (5.2) | 54.6 (4.3) | - | |||||||
| Lymphoma | 54.3 (2.2) | 47.6 (5.2) | - | |||||||
| Solid tumours | 50.8 (3.8) | 55.0 (2.9) | 58.7 (2.1) | |||||||
| Historical C.Gb. | - | 51.1 (9.1) | - | |||||||
| Lam et al. [ | T0: initial assessment (n = 70). T1: 6 months (n = 70). T2: 9 months (n = 70). | Fatigue | Chinese version of the FS-C | E.G. | 49.2 (7.5) | 48.2 (7.2) | 47.6 (7.5) | - | Statistically significant improvement in all outcome variables of the E.G. from T0 to T2. | |
| C.G. | 49.7 (6.9) | 53.7 (7.0) | 54.7 (6.7) | - | ||||||
| PA level | CUHK-PARCY questionnaire | E.G. | 2 (1.2) | - | 4 (2.0) | - | ||||
| C.G. | 2 (1.3) | - | 1.9 (1.3) | - | ||||||
| PA self-efficacy | PA-SE scale | E.G. | 7.8 (2.3) | 8.4 (1.8) | 8.6 (2.0) | - | ||||
| C.G. | 7.7 (2.7) | 6.4 (2.0) | 6.3 (2.2) | - | ||||||
| QOL | Chinese version of the PedsQL questionnaire | E.G. | 63.0 (7.1) | 64.0 (6.0) | 64.7 (6.0) | - | ||||
| C.G. | 62.3 (9.2) | 60.4 (9.0) | 58.0 (8.5) | - | ||||||
| Li et al. [ | T0: initial assessment | Fatigue | Chinese version of the FS-C | E.G. | 29.4 (4.2) | 26.6 (4.9) | 22.3 (4.2) | - | Statistically significant improvement in all outcome variables of the E.G. from T0 to T2. | |
| C.G. | 29.2 (4.1) | 28.5 (4.2) | 28.9 (4.9) | - | ||||||
| PA level | CUKH-PARCY questionnaire | E.G. | 3.0 (1.2) | 5.2 (1.6) | 6.0 (1.8) | - | ||||
| C.G: | 3.2 (1.1) | 3.3 (1.2) | 3.5 (1.6) | - | ||||||
| PA self-efficacy | PA-SE scale | E.G. | 9.1 (3.4) | 10.5 (3.0) | 11.9 (3.0) | - | ||||
| C.G. | 9.0 (3.1) | 9.1 (3.0) | 9.0 (3.1) | - | ||||||
| QOL | Chinese version of the PedsQL scale | E.G. | 68.6 (11.6) | 70.3 (11.9) | 79.8 (13.2) | - | ||||
| C.G. | 68.4 (11.5) | 68.4 (12.0) | 70.1 (12.8) | - | ||||||
| Mendoza et al. [ | T0: initial assessment (n = 59). T1: 8–10 weeks (n = 59). | PA level | Actigraph GT3X+ e accelerometer | PA minutes/day | E.G | - | +4.4 | - | - | No significant differences were found for any of the outcome variables in either of the two study groups. |
| C.G | - | +5 | - | - | ||||||
| Sedentarism | E.G | - | −4.5 | - | - | |||||
| C.G | - | +1 | - | - | ||||||
| Health-related QOL (includes pain) | PedsQL 4.0 Generic Core f scale | E.G. | 79.7 | 79.1 | - | - | ||||
| C.G. | 77.5 | 79.4 | - | - | ||||||
| PedsQL Cancer Module Scores f: bodily pain | E.G. | 73.2 | 69.6 | - | - | |||||
| C.G. | 73.5 | 70.8 | - | - | ||||||
| Ovans et al. [ | T0: initial assessment (n = 15). T1: 12 weeks (n = 15). | PA level | Objective: FitBit Flex® (steps/day) | E.G. | 8956 (4589) | 8944 (3022) | 10,141 (3260) | - | Statistically significant improvements in total, general and sleep/rest-related fatigue between T0 and T1, as well as in total and general fatigue between T0 and T2 of the 11 participants left. | |
| Subjective: leisure score index of the GLTEQ f | E.G. | 45 | 52 | 73 | - | |||||
| QOL | PedsQL Generic Core Scale f | E.G. | 84.38 | 85.50 | 91.75 | - | ||||
| Fatigue | PedsQL Multidimensional Fatigue Scale f | E.G. | Tot.F. | 72.22 | 83.33 | - | - | |||
| Gen.F. | 70.83 | 83.33 | 87.50 | |||||||
| S-R. F. | 62.50 | 75.00 | 79.17 | |||||||
| Cog.F. | 79.17 | 83.33 | 87.50 | |||||||
Abbreviations: ALL: acute lymphoblastic leukaemia; C.G.: control group; Cog.F.: cognitive fatigue; CUHK-PARCY: Chinese University of Hong-Kong Physical Activity Rating for Children and Youth; E.G.: experimental group; FS-A: Fatigue Scale—Adolescent; FS-C-: Fatigue Scale—Child; Gen.F.: general fatigue; GLTEQ: Godin-Leisure-Time Exercise Questionnaire; PA: physical activity; PA-SE: Physical Activity Self-Efficacy Scale; PedsQL: Paediatric Quality of Life Inventory; n: sample size; QOL: quality of life; SD: standard deviation; S-R. F.: sleep/rest fatigue; T0: initial assessment; T1: first assessment; T2: second assessment; T3: third assessment; Tot.F.: total fatigue. Additional information: a This questionnaire was not completed by children under 5 years of age. b These variables were evaluated in a historical control group (n = 27) from the same centre after receiving the cancer intervention (4 months) and before receiving the “Kids Are Moving” programme. c These outcomes are not presented in a numerical form, but in graphs. d Fatigue outcomes are presented for both the combined group and for each of the different cancer types. e These results were analysed by measuring the difference between T0 and T1 of the mean minutes of moderate-vigorous PA and sedentary activity in both groups. f These results are presented without standard deviation.